Inventor · disambiguated record
Ramila Philip
Also filed as: PHILIP RAMILA
24 granted patents·10 pending applications·279 citations·filing 1994–2023
95Inventor score
Files withEMERGEX VACCINES HOLDING LTD14IMMUNOTOPE INC6PHILIP RAMILA4EMERGEX VACCINES HOLDINGS LTD2RHONE POULENC RORER PHARMA2
Top patents by PatentIndex Score
34 records- 0194US7919467B2Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancerIMMUNOTOPE INC·Filed 2006·Granted Apr 5, 2011·88 cites·14 claims
- 0292US5834441AAdeno-associated viral (AAV) liposomes and methods related theretoRHONE POULENC INC·Filed 1994·Granted Nov 10, 1998·96 cites·49 claims
- 0388US9132178B2Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of cancerPHILIP RAMILA·Filed 2010·Granted Sep 15, 2015·12 cites·12 claims
- 0484US11690904B2MHC class I associated peptides for prevention and treatment of multiple flavi virusEMERGEX VACCINES HOLDING LTD·Filed 2019·Granted Jul 4, 2023·1 cites·20 claims
- 0582US12178867B2MHC class i associated peptides for prevention and treatment of multiple flavi virusEMERGEX VACCINES HOLDING LTD·Filed 2023·Granted Dec 31, 2024·0 cites·20 claims
- 0678US11273216B2Universal influenza vaccine compositionsEMERGEX VACCINES HOLDING LTD·Filed 2018·Granted Mar 15, 2022·1 cites·12 claims
- 0778US9637521B2Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of dengue virus infectionPHILIP RAMILA·Filed 2012·Granted May 2, 2017·3 cites·13 claims
- 0878US2024050548A1Mhc class i associated peptides for prevention and treatment of multiple flavi virusEMERGEX VACCINES HOLDING LTD·Filed 2023·Application pending·0 cites
- 0977US7083789B2Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancerIMMUNOTOPE INC·Filed 2001·Granted Aug 1, 2006·10 cites·10 claims
- 1076US5861314AAdeno-associated viral (AAV) liposomes and methods related theretoRHONE POULENC RORER PHARMA·Filed 1995·Granted Jan 19, 1999·28 cites·5 claims
- 1175US11931407B2MHC class I associated peptides for prevention and treatment of zika virusEMERGEX VACCINES HOLDING LTD·Filed 2022·Granted Mar 19, 2024·0 cites·20 claims
- 1272US10117922B2Dengue virus specific multiple HLA binding T cell epitopes for the use of universal vaccine developmentEMERGEX VACCINES HOLDING LTD·Filed 2015·Granted Nov 6, 2018·1 cites·6 claims
- 1371US11191828B2MHC class I associated hepatitis B peptidesEMERGEX VACCINES HOLDING LTD·Filed 2018·Granted Dec 7, 2021·0 cites·4 claims
- 1470US9907842B2Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of cancerPHILIP RAMILA·Filed 2015·Granted Mar 6, 2018·1 cites·12 claims
- 1570US2022054631A1MHC Class I Associated Hepatitis B PeptidesEMERGEX VACCINES HOLDING LTD·Filed 2021·Application pending·0 cites
- 1669US5861171AAdeno-associated viral (AAV) liposomes and methods related theretoRHONE POULENC RORER PHARMA·Filed 1995·Granted Jan 19, 1999·20 cites·3 claims
- 1764US6652850B1Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunityAVENTIS PHARMA INC·Filed 1996·Granted Nov 25, 2003·18 cites·27 claims
- 1861US10155036B2MHC class I associated peptides for prevention and treatment of hepatitis B virus infectionEMERGEX VACCINES HOLDING LTD·Filed 2015·Granted Dec 18, 2018·0 cites·8 claims
- 1960US10556929B2Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of dengue virus infectionEMERGEX VACCINES HOLDINGS LTD·Filed 2018·Granted Feb 11, 2020·0 cites·1 claims
- 2059US11426457B2MHC class I associated peptides for prevention and treatment of zika virusEMERGEX VACCINES HOLDING LTD·Filed 2018·Granted Aug 30, 2022·0 cites·5 claims
- 2158US9624284B2Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of cancerPHILIP RAMILA·Filed 2012·Granted Apr 18, 2017·0 cites·8 claims
- 2257US10206990B2Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of cancerIMMUNOTOPE INC·Filed 2017·Granted Feb 19, 2019·0 cites·8 claims
- 2353US10144766B2Cytotoxic T Lymphocyte inducing immunogens for prevention treatment and diagnosis of dengue virus infectionEMERGEX VACCINES HOLDINGS LTD·Filed 2017·Granted Dec 4, 2018·0 cites·19 claims
- 2451US11344614B2Pharmaceutical compositions comprising dengue virus-specific multiple HLA-binding T cell epitopesEMERGEX VACCINES HOLDING LTD·Filed 2018·Granted May 31, 2022·0 cites·1 claims
- 2550US2011142919A1Cytotoxic T-Lymphocyte-Inducing Immunogens for Prevention, Treatment and Diagnosis of CancerIMMUNOTOPE INC·Filed 2011·Application pending·0 cites
- 2649US12409215B2Vaccine compositionsEMERGEX VACCINES HOLDING LTD·Filed 2019·Granted Sep 9, 2025·0 cites·18 claims
- 2748US12156909B2Reverse peptide vaccineEMERGEX VACCINES HOLDING LTD·Filed 2019·Granted Dec 3, 2024·0 cites·21 claims
- 2848US2014248360A1Nanoparticle tumour vaccinesMIDATECH LTD·Filed 2012·Application pending·0 cites
- 2948US2014302124A1Cytotoxic T Lymphocyte Inducing Immunogens For Prevention Treatment and Diagnosis of INFLUENZA VIRUS INFECTIONIMMUNOTOPE INC·Filed 2012·Application pending·0 cites
- 3047US2008107668A1Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancerIMMUNOTOPE INC·Filed 2007·Application pending·0 cites
- 3145US2007248628A1Immunogens in cancer stem cellsKELLER LORRAINE H·Filed 2006·Application pending·0 cites
- 3245US2021283237A1Vaccine compositionsEMERGEX VACCINES HOLDING LTD·Filed 2019·Application pending·0 cites
- 3344US2002192229A1MHC class I associated peptides for prevention and treatment of tuberculosisFiled 2001·Application pending·0 cites
- 3440US2005239209A1Method for peptide and polypeptide purification and differential analysisKRAKOVER JONATHAN·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →